Skip to main content

Exicure, Inc.

corporate_fare Company Profile

Exicure, Inc.

Exicure, Inc. does not have significant operations. Previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed XCUR - Latest Insights

XCUR
Apr 22, 2026, 7:57 PM EDT
Source: Reuters
Importance Score:
8
Biotech Exicure Secures Co-Development Deal for Burixafor with Adbiotech
Sentiment: Positive
View Wiseek Article
XCUR
Apr 10, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Exicure Appoints New Director and Chief Operating Officer, Strengthening Governance and Operations
Sentiment: Positive
View Wiseek Article
XCUR
Apr 02, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Exicure Settles Stockholder Derivative Lawsuits, Implements Key Governance Reforms
Sentiment: Positive
View Wiseek Article
XCUR
Mar 27, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7
Audit Committee Member Resigns from Financially Troubled Exicure
Sentiment: Negative
View Wiseek Article
XCUR
Mar 27, 2026, 4:40 PM EDT
Filing Type: 8-K
Importance Score:
7
Director Resigns Amidst Going Concern Doubts
Sentiment: Neutral
View Wiseek Article
XCUR
Mar 25, 2026, 4:42 PM EDT
Filing Type: 10-K
Importance Score:
9
EXICURE Faces Substantial Doubt as Going Concern Amidst Low Cash, Legal Battles, and Internal Control Weaknesses
Sentiment: Negative
View Wiseek Article
XCUR
Mar 25, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
9
Exicure Issues Going Concern Warning Amidst Critical $3.7M Cash Position
Sentiment: Negative
View Wiseek Article
XCUR
Mar 25, 2026, 4:18 PM EDT
Source: GlobeNewswire
Importance Score:
9
Exicure Issues Going Concern Warning as Cash Dips to $3.7M for FY2025
Sentiment: Negative
View Wiseek Article
XCUR
Feb 17, 2026, 5:25 PM EST
Filing Type: 8-K
Importance Score:
8
Exicure Appoints New CEO and Interim CFO, Filling Key Leadership Vacancies
Sentiment: Positive
View Wiseek Article
XCUR
Feb 10, 2026, 4:25 PM EST
Filing Type: 8-K
Importance Score:
9
Exicure Announces CEO, CFO Resignations and Major Board Overhaul
Sentiment: Negative
View Wiseek Article
XCUR
Jan 22, 2026, 4:29 PM EST
Filing Type: 8-K
Importance Score:
8
Exicure Achieves Phase 2 Clinical Milestone for Stem Cell Mobilizer, Triggers $1M Payment and Enhanced Sublicensing Terms
Sentiment: Positive
View Wiseek Article
XCUR
Jan 21, 2026, 1:21 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Major Shareholder Exicure HiTron Inc. Reduces Stake in EXICURE, INC.
Sentiment: Negative
View Wiseek Article
XCUR
Jan 21, 2026, 12:46 PM EST
Filing Type: 4
Importance Score:
7
10% Owner Exicure HiTron Inc. Sells $1.16M in EXICURE, INC. Stock
Sentiment: Negative
View Wiseek Article
XCUR
Jan 20, 2026, 5:48 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Major Shareholder Exicure HiTron Inc. Sells $3.3M in Shares, Reducing Stake to 29.2%
Sentiment: Negative
View Wiseek Article
XCUR
Jan 20, 2026, 2:09 PM EST
Filing Type: 4
Importance Score:
8
10% Owner Sells Over $3.3M in EXICURE, INC. Shares
Sentiment: Negative
View Wiseek Article
XCUR
Jan 09, 2026, 8:09 AM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Major Shareholder Exicure HiTron Sells $3.3M in EXICURE Stock, Reducing Stake to 40.7%
Sentiment: Negative
View Wiseek Article
XCUR
Jan 08, 2026, 8:42 PM EST
Filing Type: 4
Importance Score:
8
10% Owner Exicure HiTron Inc. Sells $3.3M in XCUR Shares, Reducing Stake by Over 22%
Sentiment: Negative
View Wiseek Article